Page last updated: 2024-10-29

piperidine-4-carboxamide and Alzheimer Disease

piperidine-4-carboxamide has been researched along with Alzheimer Disease in 2 studies

piperidine-4-carboxamide: structure in first source

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Purgatorio, R1
Gambacorta, N1
de Candia, M1
Catto, M1
Rullo, M1
Pisani, L1
Nicolotti, O1
Altomare, CD1
Dileep, KV1
Sakai, N1
Ihara, K1
Kato-Murayama, M1
Nakata, A1
Ito, A1
Sivaraman, DM1
Shin, JW1
Yoshida, M1
Shirouzu, M1
Zhang, KYJ1

Other Studies

2 other studies available for piperidine-4-carboxamide and Alzheimer Disease

ArticleYear
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease.
    Molecules (Basel, Switzerland), 2021, Aug-27, Volume: 26, Issue:17

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cattle; Cholinesterase Inhi

2021
Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors.
    International journal of biological macromolecules, 2021, Feb-15, Volume: 170

    Topics: Alzheimer Disease; Aminoacyltransferases; Amyloid beta-Peptides; Brain; Cell Line, Tumor; Humans; Mo

2021